Skip to main content
Lynn Million, MD, Radiation Oncology, Stanford, CA, Stanford Health Care


Radiation Oncology Stanford, CA

Pediatric Radiation Oncology, Sarcoma, Skin Cancer

Clinical Associate Professor, Radiation Oncology, Stanford University Medical Center

Dr. Million is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Million's full profile

Already have an account?

Education & Training

  • Stanford University
    Stanford UniversityResidency, Radiation Oncology, 1987 - 1990
  • Atlanta Medical CenterInternship, Transitional Year, 1986 - 1987
  • University of Florida
    University of FloridaClass of 1986
  • Florida State UniversityB.S., 1976 - 1981

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - 2022
  • UT State Medical License
    UT State Medical License 1991 - 2012
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Career Development Award ACS, 1993
  • Robert R. Newell Award 1991
  • Join now to see all

Publications & Presentations


Journal Articles

  • Survival and Neurocognitive Outcomes Following Addition of a Cranial or Craniospinal Boost to Total Body Irradiation Prior to Stem Cell Transplantation in Pediatric Le...  
    Hiniker SM, Agarwal R, Modlin LA, Gray CC, Harris JP, Million L, Kiamanesh EF, Donaldson SS, Int J Radiat Oncol Biol Phys, 1/1/2014
  • Successful treatment with temozolomide combined with chemo-radiotherapy and surgery of a metastatic undifferentiated soft tissue sarcoma with relapse in the central ne...  
    Hsu C, Daldrup-Link H, Yeom K, Donaldson S, Million L, Hazard, Rangaswami A, Journal of Adolescent and Young Adult Oncology, 1/1/2014
  • Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from three...  
    28. Hoppe R, Harrison C, Tavallaee M, Bashey S, Sundram U, Li S, Million L, Dabaja B, Duvic M, Gangar, Kim Y, J Am Acad Derm, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all


  • Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age: Children's Oncology Group Study ARST0332.
    Spunt SL, Million L, Anderson JR, Coffin CM, McCarville MB, Randall RL, Parham D, Kao SCS, Hayes-Jordan A, Wolden S, Black J, Laurie F, Tsan E, Speights R, Skapek SX, ..., ASCO, Chicago, IL, 1/1/2014
  • Vincristine, dactinomycin, cyclophosphamide (VAC) vs VAC/V+irinotecan (VI) for intermediate risk rhabdomyosarcoma (IRRMS): a report from the Children's Oncology Group ...
    Hawkins, D, Anderson JR , Mascarenhas L, McCowage G, Rodeberg D, Wolden S, Parham D, Million L, Donaldson S, Hayes-Jordan A, Brown K, Teot L, Spunt S, Meyer W, ASCO, Chicago, IL, 1/1/2014
  • Low dose (12 Gy) total skin electron beam therapy (TSEBT) for mycosis fungoides (MF): Results of three phase 2 clinical trials.
    Hoppe, Harrison C, Tavallaee M, Bashey S, Li S, Million L, Dabaja B, Duvic M, Kim Y, ASTRO, San Francisco, CA, 1/1/2014
  • Join now to see all


  • Low dose (12 Gy) total skin electron beam therapy (TSEBT) for mycosis fungoides (MF): Results of three phase 2 clinical trials. 
    San Francisco, CA - 1/1/2014
  • Local control among young patients with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS) following risk-based treatment: results from children's oncology group (COG) s... 
    Berlin - 1/1/2014
  • "Onco-diagnosis: Pedatric Soft tissue Sarcoma's" 
    Chicago, IL - 1/1/2013
  • Join now to see all


  • Pediatric Soft Tissue Sarcoma's: The Role of Radiation Therapy. 
    Smith LM, MD Vista Journal

Hospital Affiliations